BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16618534)

  • 1. Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination.
    de Bree E; Rosing H; Michalakis J; Romanos J; Relakis K; Theodoropoulos PA; Beijnen JH; Georgoulias V; Tsiftsis DD
    Eur J Surg Oncol; 2006 Aug; 32(6):666-70. PubMed ID: 16618534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: from laboratory bench to bedside.
    de Bree E; Theodoropoulos PA; Rosing H; Michalakis J; Romanos J; Beijnen JH; Tsiftsis DD
    Cancer Treat Rev; 2006 Oct; 32(6):471-82. PubMed ID: 16942841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin.
    de Bree E; Romanos J; Michalakis J; Relakis K; Georgoulias V; Melissas J; Tsiftsis DD
    Anticancer Res; 2003; 23(3C):3019-27. PubMed ID: 12926156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
    Muñoz-Casares FC; Rufián S; Arjona-Sánchez Á; Rubio MJ; Díaz R; Casado Á; Naranjo Á; Díaz-Iglesias CJ; Ortega R; Muñoz-Villanueva MC; Muntané J; Aranda E
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):267-74. PubMed ID: 21499894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy time interval and development of platinum and taxane resistance in ovarian, fallopian, and peritoneal carcinomas.
    Matsuo K; Eno ML; Im DD; Rosenshein NB
    Arch Gynecol Obstet; 2010 Feb; 281(2):325-8. PubMed ID: 19455347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal taxanes.
    Mohamed F; Sugarbaker PH
    Surg Oncol Clin N Am; 2003 Jul; 12(3):825-33. PubMed ID: 14567034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taxanes in ovarian cancer treatment.
    Seetalarom K; Kudelka AP; Verschraegen CF; Kavanagh JJ
    Curr Opin Obstet Gynecol; 1997 Feb; 9(1):14-20. PubMed ID: 9090476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
    Morgan RJ; Doroshow JH; Synold T; Lim D; Shibata S; Margolin K; Schwarz R; Leong L; Somlo G; Twardowski P; Yen Y; Chow W; Lin P; Paz B; Chu D; Frankel P; Stalter S
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5896-901. PubMed ID: 14676112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
    Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer.
    de Bree E; Rosing H; Beijnen JH; Romanos J; Michalakis J; Georgoulias V; Tsiftsis DD
    Anticancer Drugs; 2003 Feb; 14(2):103-10. PubMed ID: 12569296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm.
    Terauchi F; Moritake T; Yamamoto Y; Ogura H
    Int J Clin Oncol; 2002 Dec; 7(6):356-60. PubMed ID: 12494251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of hyperthermic intraperitoneal intraoperative chemotherapy in ovarian cancer.
    van Driel WJ; Lok CA; Verwaal V; Sonke GS
    Curr Treat Options Oncol; 2015 Apr; 16(4):14. PubMed ID: 25796375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.
    Vasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SB;
    J Natl Cancer Inst; 2004 Nov; 96(22):1682-91. PubMed ID: 15547181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.
    Rufián S; Muñoz-Casares FC; Briceño J; Díaz CJ; Rubio MJ; Ortega R; Ciria R; Morillo M; Aranda E; Muntané J; Pera C
    J Surg Oncol; 2006 Sep; 94(4):316-24. PubMed ID: 16917864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.